Irina C Jacobson

This inventor holds 27 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 7 EPO patents, primarily in Antiviral Therapeutics. Top assignees: Cocrystal Pharma, Inc., Bristol-Myers Squibb Pharma Company, Cocrystal, Discovery, Inc.. Active years: 2002-2026.

USPTO Granted Patents = 27 (Patent Applications = 4)

% Patents Active = 77.8

CIPO Patents = 1 (Patent Applications = 7)

EPO Patents = 7 (Patent Applications = 11)

Average Co-Inventor Count = 3.2

ph-index = 8

Forward Citations = 158(Granted Patents)

Location History:

Wilmington, DE (US) (2002 - 2004)
Sammamish, VA (US) (2004)
Sammamish, WA (US) (2004 - 2024)

Company Filing History:

11 out of 18

Cocrystal Pharma, Inc.

patents

8 out of 234

Bristol-Myers Squibb Pharma Company

patents

2 out of 2

Cocrystal, Discovery, Inc.

patents

4. 1 out of 2,405

Merck Sharp + Dohme Corp.

6. 5 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 2002-2026

Loading Chart...

Areas of Expertise:

Norovirus Inhibitors

Coronavirus Inhibitors

Influenza Replication

Hepatitis C Polymerase

Pyrrolo Derivatives

Combination Therapy

Tetracycline Derivatives

Factor Xa Inhibitors

Thrombin Inhibitors

Aryl Sulfonyls

Pyridopyrazine

Heterocycles

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12649715 - Inhibitors of norovirus and coronavirus replication (2026-06-09),

2. 12565488 - Inhibitors of influenza virus replication (2026-03-03),

3. 12357631 - Pyrrolo[2,3-B]pyridin derivatives as inhibitors of influenza virus replication (2025-07-15),

4. 12233066 - Combinations of inhibitors of influenza virus replication (2025-02-25),

5. 12156876 - Formulations of influenza therapeutics (2024-12-03),

6. 12037333 - Pyridopyrazine and pyridotriazine inhibitors of influenza virus replication (2024-07-16),

7. 11752166 - Combination therapy for treatment of HCV (2023-09-12),

8. 11014941 - Pyrrolopyrimidine derivatives useful as inhibitors of influenza virus replication (2021-05-25),

9. 10947210 - Inhibitors of Hepatitis C virus polymerase (2021-03-16),

10. 10464914 - Inhibitors of hepatitis C virus polymerase (2019-11-05),

11. 10426762 - Inhibitors of hepatitis C virus polymerase (2019-10-01),

12. 9896422 - Tetracycline derivatives with reduced antibiotic activity and neuroprotective benefits (2018-02-20),

13. 9707215 - Inhibitors of hepatitis C virus polymerase (2017-07-18),

14. 9573912 - Tetracycline derivatives with reduced antibiotic activity and neuroprotective benefits (2017-02-21),

15. 9168265 - Tetracycline derivatives with reduced antibiotic activity and neuroprotective benefits (2015-10-27),

Title: The Innovative Journey of Irina C Jacobson

Introduction: Irina C Jacobson, a pioneering inventor based in Sammamish, WA (US), has made significant contributions to the field of technology with her groundbreaking inventions.

Latest Patents: Irina C Jacobson holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing her diverse range of expertise and innovative spirit.

Career Highlights: With a career spanning over two decades, Irina C Jacobson has established herself as a leading figure in the tech industry, known for her ability to transform bold ideas into tangible solutions. Her work has not only revolutionized existing technologies but has also paved the way for future innovations.

Collaborations: Throughout her career, Irina C Jacobson has collaborated with top research institutions, leading companies, and brilliant minds in the industry. These collaborations have not only enhanced the quality of her inventions but have also fostered a culture of innovation and creativity.

Conclusion: Irina C Jacobson's relentless pursuit of innovation and her passion for pushing the boundaries of technology have solidified her position as a trailblazer in the field of inventions. Her work continues to inspire the next generation of inventors and serves as a testament to the power of creativity and perseverance in driving meaningful change.